Form 4: Solid Biosciences Director Ian F. Smith Reports Stock Transactions
SEC Form 4 Filing
Director Ian F. Smith of Solid Biosciences Inc. reports the vesting of restricted stock units into common stock on October 3, 2024.
Summary
- On October 3, 2024, Ian F. Smith, a director of Solid Biosciences Inc., reported a transaction involving restricted stock units.
- 3,255 restricted stock units vested and converted into 3,255 shares of common stock.
- Following the transaction, Smith directly owns 109,717 shares of Solid Biosciences Inc.
- The restricted stock units were granted on January 3, 2024, and vest in equal quarterly installments.
Sentiment
Score: 5
Explanation: This is a neutral report of insider trading activity, with no inherent positive or negative implications.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine vesting of previously granted equity.
Key Dates
| Date | Description |
|---|---|
| 2024-01-03 | Grant Date of the restricted stock units |
| 2024-10-03 | Transaction date: vesting of restricted stock units and conversion to common stock |
| 2024-10-04 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.